LGALS9 and glioblastoma: Complementing these tumour-intrinsic mechanisms, LGALS9 appears to play a pivotal role in immune evasion and immunosuppression in the glioblastoma microenvironment, consistent with emerging evidence from recent immunogenomic studies.